News
July 25 (Reuters) - The U.S. Food and Drug Administration has extended its review of Bayer's (BAYGn.DE), opens new tab experimental menopause relief drug, the German drugmaker said on Friday. The ...
All menopause treatments containing the hormone estrogen are mandated by the US Food and Drug Administration to carry a black ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback